AI4Eyes Closes $6.5M CAD in Funding
AI4Eyes, a Montréal, Canada–based AI-driven eye care startup, has secured $6.5 million CAD in funding.
The funding round comprises a $3.7 million CAD internal financing round from existing investors in Q4 2025, alongside $2.8 million CAD in non-dilutive funding.
The company will use the funds to accelerate regulatory approvals in Canada and the U.S., advance product development, expand clinical trials and data collection, and support commercialization and strategic partnerships.
AI4Eyes is a SaaS health tech company that offers an AI-powered system integrating clinical-grade imaging, diagnosis, treatment, and care recommendations into a single modular platform. Its solution is designed to improve diagnostics and treatment for eye health providers. The company focuses on creating AI-powered products that enhance clinical decision-making, streamline care workflows, and expand access to high-quality eye care globally. Headquartered in Montréal, Canada, AI4Eyes’s mission is to deliver the best experience to eye care professionals and their patients through AI, expert-validated insights, and continuous innovation.
Funding Details
Company: AI4Eyes Medical Technologies Inc.
Raised: $6.5M CAD
Round: Internal Financing + Non-Dilutive Funding
Funding Date: January 2026
Lead Investor: Undisclosed
Additional Investors: Undisclosed
Company Website: https://www.aiforeyes.com/
Software Category: AI Healthcare / Ophthalmology